Published in Biophys J on February 17, 2015
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science (2007) 20.32
Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys J (1999) 13.18
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science (2008) 11.74
Determination of domain structure of proteins from X-ray solution scattering. Biophys J (2001) 10.39
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science (2010) 10.30
Protein disorder prediction: implications for structural proteomics. Structure (2003) 7.93
Global rigid body modeling of macromolecular complexes against small-angle scattering data. Biophys J (2005) 7.10
Structural characterization of flexible proteins using small-angle X-ray scattering. J Am Chem Soc (2007) 6.53
Structure of an agonist-bound human A2A adenosine receptor. Science (2011) 6.21
Solution structure of a calmodulin-target peptide complex by multidimensional NMR. Science (1992) 6.16
A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure (2008) 6.01
The DISOPRED server for the prediction of protein disorder. Bioinformatics (2004) 5.98
FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics (2005) 5.44
Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex. Science (1992) 4.89
Calmodulin: a prototypical calcium sensor. Trends Cell Biol (2000) 4.67
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature (2011) 4.60
Sequence motifs for calmodulin recognition. FASEB J (1997) 4.38
Modulation of calmodulin plasticity in molecular recognition on the basis of x-ray structures. Science (1993) 3.75
Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation. Protein Sci (2006) 3.73
RefDB: a database of uniformly referenced protein chemical shifts. J Biomol NMR (2003) 3.68
Structural basis for allosteric regulation of GPCRs by sodium ions. Science (2012) 3.40
Calmodulin target database. J Struct Funct Genomics (2000) 3.20
Calcium binding and conformational response in EF-hand proteins. Trends Biochem Sci (1996) 3.13
Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J Biol Chem (1989) 2.95
Reassessing random-coil statistics in unfolded proteins. Proc Natl Acad Sci U S A (2004) 2.93
Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure (2011) 2.84
Assessing protein disorder and induced folding. Proteins (2006) 2.33
XtalPred: a web server for prediction of protein crystallizability. Bioinformatics (2007) 2.26
Signalling functions of protein palmitoylation. Biochim Biophys Acta (1998) 2.24
The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor. Mol Pharmacol (2005) 2.21
GPCR monomers and oligomers: it takes all kinds. Trends Neurosci (2008) 1.97
G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody. Nature (2012) 1.82
Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry (1973) 1.81
Rescue of p53 blockage by the A(2A) adenosine receptor via a novel interacting protein, translin-associated protein X. Mol Pharmacol (2006) 1.77
Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins. Br J Pharmacol (2012) 1.69
Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design. J Med Chem (2012) 1.60
Calmodulin signaling: analysis and prediction of a disorder-dependent molecular recognition. Proteins (2006) 1.51
A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization. Br J Pharmacol (2007) 1.47
Energetics of target peptide binding by calmodulin reveals different modes of binding. J Biol Chem (2001) 1.44
Phosphorylation and calmodulin binding of the metabotropic glutamate receptor subtype 5 (mGluR5) are antagonistic in vitro. J Biol Chem (1997) 1.32
G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats. J Mol Endocrinol (2009) 1.31
Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex. Sci Signal (2010) 1.31
The A(2A)-adenosine receptor: a GPCR with unique features? Br J Pharmacol (2008) 1.29
Internalization and desensitization of adenosine receptors. Purinergic Signal (2007) 1.21
Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch. J Biol Chem (2000) 1.21
How random is a highly denatured protein? Biophys Chem (1994) 1.19
A relationship between protein kinase C phosphorylation and calmodulin binding to the metabotropic glutamate receptor subtype 7. J Biol Chem (1999) 1.18
An expression system of rat calmodulin using T7 phage promoter in Escherichia coli. Protein Expr Purif (1998) 1.13
Domain coupling in GPCRs: the engine for induced conformational changes. Trends Pharmacol Sci (2011) 1.12
Calmodulin interacts with the third intracellular loop of the serotonin 5-hydroxytryptamine1A receptor at two distinct sites: putative role in receptor phosphorylation by protein kinase C. J Biol Chem (2004) 1.09
Ca2+ regulates T-cell receptor activation by modulating the charge property of lipids. Nature (2012) 1.09
Physical interaction of calmodulin with the 5-hydroxytryptamine2C receptor C-terminus is essential for G protein-independent, arrestin-dependent receptor signaling. Mol Biol Cell (2008) 1.08
Palmitoylation of human endothelinB. Its critical role in G protein coupling and a differential requirement for the cytoplasmic tail by G protein subtypes. J Biol Chem (1997) 1.06
Calmodulin binding to G protein-coupling domain of opioid receptors. J Biol Chem (1999) 1.05
Interaction of calmodulin with the serotonin 5-hydroxytryptamine2A receptor. A putative regulator of G protein coupling and receptor phosphorylation by protein kinase C. J Biol Chem (2005) 1.04
The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin. J Biol Chem (2003) 1.03
Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors. J Biol Chem (2009) 1.02
Calmodulin interacts with the V2 vasopressin receptor: elimination of binding to the C terminus also eliminates arginine vasopressin-stimulated elevation of intracellular calcium. J Biol Chem (2004) 1.00
Characterization of the A2AR-D2R interface: focus on the role of the C-terminal tail and the transmembrane helices. Biochem Biophys Res Commun (2010) 0.98
A structural insight into lead neurotoxicity and calmodulin activation by heavy metals. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.97
Calmodulin binding to peptides derived from the i3 loop of muscarinic receptors. Pharm Res (2006) 0.95
Characterization of peptides corresponding to the seven transmembrane domains of human adenosine A2a receptor. Biochemistry (2004) 0.94
From cradle to twilight: the carboxyl terminus directs the fate of the A(2A)-adenosine receptor. Biochim Biophys Acta (2010) 0.94
Calmodulin interacts with the cytoplasmic tails of the parathyroid hormone 1 receptor and a sub-set of class b G-protein coupled receptors. FEBS Lett (2005) 0.91
Palmitoylation occurs at cysteine 347 and cysteine 351 of the dopamine D(1) receptor. Eur J Pharmacol (1999) 0.90
Palmitoylation of the V2 vasopressin receptor. Mol Pharmacol (1997) 0.90
How calmodulin interacts with the adenosine A(2A) and the dopamine D(2) receptors. J Proteome Res (2008) 0.89
Calmodulin regulates Ca2+-sensing receptor-mediated Ca2+ signaling and its cell surface expression. J Biol Chem (2010) 0.89
Identification of an A2a adenosine receptor domain specifically responsible for mediating short-term desensitization. Biochemistry (1997) 0.88
Structural analysis of the complex between calmodulin and full-length myelin basic protein, an intrinsically disordered molecule. Amino Acids (2009) 0.88
A serine point mutation in the adenosine A2AR C-terminal tail reduces receptor heteromerization and allosteric modulation of the dopamine D2R. Biochem Biophys Res Commun (2010) 0.85
Charge isomers of myelin basic protein: structure and interactions with membranes, nucleotide analogues, and calmodulin. PLoS One (2011) 0.83
The neuronal Ca(2+) -binding protein 2 (NECAB2) interacts with the adenosine A(2A) receptor and modulates the cell surface expression and function of the receptor. Mol Cell Neurosci (2007) 0.83
Neurotensin receptor-1 inducible palmitoylation is required for efficient receptor-mediated mitogenic-signaling within structured membrane microdomains. Cancer Biol Ther (2011) 0.83
Characterization of intrinsically disordered prostate associated gene (PAGE5) at single residue resolution by NMR spectroscopy. PLoS One (2011) 0.83
Calcium-mediated modulation of the quaternary structure and function of adenosine A2A-dopamine D2 receptor heteromers. Curr Opin Pharmacol (2009) 0.82
Calmodulin interaction with peptides from G-protein coupled receptors measured with S-Tag labeling. Biochem Biophys Res Commun (2005) 0.81
Bridge over troubled proline: assignment of intrinsically disordered proteins using (HCA)CON(CAN)H and (HCA)N(CA)CO(N)H experiments concomitantly with HNCO and i(HCA)CO(CA)NH. J Biomol NMR (2013) 0.80
Juxtanodin is an intrinsically disordered F-actin-binding protein. Sci Rep (2012) 0.80
NCS-1 associates with adenosine A(2A) receptors and modulates receptor function. Front Mol Neurosci (2012) 0.78
An intraresidual i(HCA)CO(CA)NH experiment for the assignment of main-chain resonances in 15N, 13C labeled proteins. J Biomol NMR (2009) 0.78